• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

FDA Clearance

Movano Health Receives FDA Clearance for Evie Ring Pulse Oximeter

by Jasmine Pennic 12/03/2024 Leave a Comment

Movano Health Receives FDA Clearance for Evie Ring Pulse Oximeter

What You Should Know:  - Movano Health, a health technology innovator, has achieved a significant milestone with the FDA 510(k) clearance of the pulse oximeter integrated into its Evie Ring.  - The FDA clearance paves the way for Movano to pursue new opportunities in health monitoring solutions, including clinical trials, post-clinical management, and remote patient monitoring. Addressing the Limitations of Traditional Pulse Oximeters Traditional pulse oximeters can be
Read More

RSNA: Nonin Medical Launches First FDA-Cleared OTC Fingertip Pulse Oximeter for Accurate Readings Across Skin Tones

by Fred Pennic 12/02/2024 Leave a Comment

What You Should Know:  - Nonin Medical, a global leader in noninvasive medical monitoring lauches TruO2 OTC, the first over-the-counter (OTC) fingertip pulse oximeter to receive FDA clearance. This innovative device is designed to provide accurate blood oxygen saturation readings for adults across all skin tones, empowering individuals to make informed healthcare decisions. - Nonin Medical's founder, Phil Isaacson, was the original inventor of the fingertip pulse oximeter.  The
Read More

GE HealthCare Receives FDA Clearance for SIGNA™ MAGNUS Head-Only MRI Scanner

by Syed Hamza Sohail 11/14/2024 Leave a Comment

GE HealthCare Receives FDA Clearance for SIGNA™ MAGNUS Head-Only MRI Scanner

What You Should Know: - GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.  - This system offers new capabilities for both clinical imaging and neuroscience with the potential to aid in the detection of neurological, oncological, and psychiatric conditions. SIGNA MAGNUS: Advancing Neuroimaging with Cutting-Edge MRI Technology The FDA clearance of the SIGNA MAGNUS
Read More

AccurKardia’s AI-Powered ECG Software Earns FDA Breakthrough Device Designation for Aortic Stenosis Detection

by Syed Hamza Sohail 10/08/2024 Leave a Comment

AccurKardia's AI-Powered ECG Software Earns FDA Breakthrough Device Designation for Aortic Stenosis Detection

What You Should Know: -   AccurKardia, an innovator in ECG-based diagnostics technology, has announced that its Aortic Valve Stenosis (AVS) ECG-based AI screening software has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). -  The company’s AVS screening software aims to leverage the ubiquity of the electrocardiogram (ECG) to identify potential cases of AVS within millions of ECGs already present in healthcare system electronic health records in
Read More

BioIntelliSense Optimizes Hospital Virtual Care with FDA-Cleared Rechargeable BioButton

by Fred Pennic 10/07/2024 Leave a Comment

BioIntelliSense Optimizes Hospital Virtual Care with FDA-Cleared Rechargeable BioButton

What You Should Know:  - BioIntelliSense, a leader in continuous health monitoring, has received FDA clearance for its rechargeable BioButton Multi-Patient wearable and BioDashboard system.  - The BioButton is poised to transform hospital virtual care programs by providing a cost-effective and scalable solution for continuous patient monitoring. Rechargeable and Reusable Wearable  The BioButton Multi-Patient wearable is a game-changer for inpatient settings. This
Read More

GE HealthCare Receives FDA Clearance for Innovative Alzheimer’s Imaging Tool

by Fred Pennic 10/04/2024 Leave a Comment

GE HealthCare Receives FDA Clearance for Innovative Alzheimer's Imaging Tool

What You Should Know:  - GE HealthCare announced today that its MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a groundbreaking tool in the fight against Alzheimer's disease.  - The advancement allows MIMneuro, a vendor-neutral software solution, to perform "Centiloid scaling" for analyzing and quantifying amyloid plaque density in the brain using positron emission tomography (PET) imaging. Impact of Alzheimer's
Read More

Withings Sleep Rx Receives FDA Clearance for Home Sleep Apnea Testing

by Jasmine Pennic 09/09/2024 Leave a Comment

Withings Sleep Rx Receives FDA Clearance for Home Sleep Apnea Testing

What You Should Know:  - Withings, a global leader in connected health, has announced that its Sleep Rx sleep apnea device has received clearance from the U.S. Food and Drug Administration (FDA).  - Sleep Rx represents a significant advancement in the diagnosis of sleep apnea, offering a more convenient and accurate alternative to traditional in-lab testing. Addressing the Underdiagnosis of Sleep Apnea Sleep apnea is a serious condition that affects millions of people
Read More

Qure.ai Receives FDA Clearance for AI-Powered Lung Nodule Analysis Tool

by Syed Hamza Sohail 08/23/2024 Leave a Comment

Qure.ai Receives FDA Clearance for AI-Powered Lung Nodule Analysis Tool

What You Should Know: - Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant. - The new AI solution is now available to support radiologists and pulmonologists in analyzing lung nodules on non-contrast chest CT scans and tracking volumetric growth as part of progression monitoring. Qure.ai Enhances Lung Cancer Care with AI-Powered qCT LN Quant Qure.ai has integrated qCT LN Quant into
Read More

AISAP’s AI-Powered Cardiac Ultrasound Receives FDA Clearance

by Jasmine Pennic 08/22/2024 Leave a Comment

FDA Clears First AI-assisted Point-of-Care Software for Structural Heart Disease and Heart Failure Diagnosis

What You Should Know:  - AISAP, a medical technology company specializing in AI-powered point-of-care assisted diagnosis (POCAD) solutions, announced today that it has received FDA 510(k) clearance for its groundbreaking CARDIO software platform.  - AISAP CARDIO is a cloud-based software package that combines four computer-assisted diagnosis (CADx) modules for valvular pathologies and eight key measurements into a single, user-friendly platform.  Point-of-Care
Read More

Diality Receives FDA Clearance for Innovative Hemodialysis System

by Fred Pennic 08/06/2024 Leave a Comment

Diality Receives FDA Clearance for Innovative Hemodialysis System

What You Should Know:  - Diality, a medical device company focused on advancing kidney care, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Moda-flx Hemodialysis System™.  - The Moda-flx Hemodialysis System is designed to enhance the dialysis experience for both patients and healthcare providers. With its variable flow rate ranges, integrated reverse osmosis water filtration, and user-friendly interface, clinicians
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 10
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

HHS Finalizes HTI-4 Rule: Prior Authorization & E-Prescribing Interoperability

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low, But AI Dominates and $1B+ IPOs Emerge

Healthcare Investment Shifts in 1H 2025: AI Remains a Bright Spot Amidst Fundraising Decline

Digital Health Faces Q2'25 Pullback: Funding Falls to 5-Year Low

Digital Health Faces Q2’25 Pullback: Funding Falls to 5-Year Low

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Beyond the Hype: Building AI Systems in Healthcare Where Hallucinations Are Not an Option

Health IT Sector Navigates Policy Turbulence with Resilient M&A

Health IT’s New Chapter: IPOs Return, Resilient M&A, Valuations Rise in 1H 2025

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

PwC Report: US Medical Cost Trend to Remain Elevated at 8.5% in 2026

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Philips Launches ECG AI Marketplace, Partnering with Anumana to Enhance Cardiac Care with AI-Powered Diagnostics

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |